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Abstract
Background: Swiss ambulatory care is characterized by independent, and primarily practice-based, physicians,
receiving fee for service reimbursement. This study analyses supply sensitive services using ambulatory care claims
data from mandatory health insurance. A first research question was aimed at the hypothesis that physicians with
large patient lists decrease their intensity of services and bill less per patient to health insurance, and vice versa:
physicians with smaller patient lists compensate for the lack of patients with additional visits and services. A
second research question relates to the fact that several cantons are allowing physicians to directly dispense drugs
to patients (’self-dispensation’) whereas other cantons restrict such direct sales to emergencies only. This second
question was based on the assumption that patterns of rescheduling patients for consultations may differ across
channels of dispensing prescription drugs and therefore the hypothesis of different consultation costs in this
context was investigated.
Methods: Complete claims data paid for by mandatory health insurance of all Swiss physicians in own practices
were analyzed for the years 2003-2007. Medical specialties were pooled into six main provider types in ambulatory
care: primary care, pediatrics, gynecology & obstetrics, psychiatrists, invasive and non-invasive specialists. For each
provider type, regression models at the physician level were used to analyze the relationship between the number
of patients treated and the total sum of treatment cost reimbursed by mandatory health insurance.
Results: The results show non-proportional relationships between patient numbers and total sum of treatment
cost for all provider types involved implying that treatment costs per patient increase with higher practice size. The
related additional costs to the health system are substantial. Regions with self-dispensation had lowest treatment
cost for primary care, gynecology, pediatrics and for psychiatrists whereas “prescription only” areas had lowest cost
for specialists with non-invasive and invasive activities.
Conclusions: The results indicate that payment methods for services and for prescription drugs are associated with
variations in treatment cost that are unlikely warranted by different medical needs of patients alone. Promoting
physician accountability of care by linking reimbursements to quality, not quantity, of services are important policy
measures to be considered for health care in Switzerland.
Background
The Swiss health system is based on regulated competi-
tion of insurers and providers, [1] and is regarded as
one of the role models for American health care reform.
Swiss health care shares many characteristics with the
United States while also suffering from some similar ills.
Ambulatory health care in Switzerland is characterized
by independent physicians working mostly in their own
practices and are reimbursed on a fee-for-service basis.
Patients have direct access to physician specialists with
little gate-keeping to regulate access. Hospital ownership
is both public and private with payments from cantons
and insurers.
Similar to the future mandates of U.S. health care
reform, Swiss residents must purchase health insurance
individually from competing insurance companies.
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This mandatory insurance pays for a standardized basic
benefit package that includes a wide range of health ser-
vices [2]. Insurance is offered by almost 100 companies
with public subsidizes provided to the less affluent and
insurers are not allowed to make profits with basic
health insurance. Switzerland’s health care expenditures
are also near the top of developed countries with 11.6%
of GDP. Not surprisingly, during an era of low eco-
nomic growth, costs and quality are perennial concerns
of patients, providers, and policy makers.
This paper examines reimbursements for Swiss ambu-
latory care. In 2007, ambulatory care services accounted
for 22% of total cost in Swiss health care and only 17%
of the population had a insurance policy with some
form of restricted access to health care providers [3].
Previous research has documented considerable geo-
graphic and temporal variation of per capita health care
costs in the Swiss ambulatory sector, and several asso-
ciated factors were identified [4-6]. Other research
shows that there might be an optimal list size (i.e. panel
size) of patients per general practitioner for providing
efficient and high quality care [7]. The present study
refines and expands this research by addressing two
research questions through the analyses of the complete
set of mandatory health insurance consultation claims
provided by all ambulatory Swiss physicians during the
years 2003-2007 (i.e. of 54% Swiss physician workforce
in 2007).
The first question is whether physicians’ practice list
size is inversely related to the intensity of services and
billings per patient; that is, do physicians with shorter
patient lists “compensate” with additional services? An
association of practice list size and treatment intensity
would raise concerns that fee-for-service payment incen-
tivize a higher volume of care without regard to patient
needs [8].
The second research question focuses more narrowly
on whether prescription drug reimbursement is related
to treatment intensity? Several cantons are allowing
physicians to directly dispense drugs to patients (’self-
dispensation’), while other cantons restrict such direct
sales to emergencies only and patients must obtain
repeat prescription drugs in a pharmacy (’prescription
only’). Some cantons allow both types of dispensation
(mixed forms). An association between canton prescrip-
tion drug dispensing policies and service intensity and
consultation costs may be a further indication of a misa-
lignment of reimbursement policies and patient needs.
Methods
Claims data were obtained from santésuisse, the
umbrella organization of Swiss health insurers. Physi-
cians were classified into 49 different medical specialties
with board certifications according to the Swiss Medical
Association (FMH), together with practice location area
codes. Medical specialties were pooled into six main
provider types: primary care, pediatrics, gynecology &
obstetrics, psychiatrists, invasive (i.e. doing mainly thera-
peutic operations as e.g. surgery, orthopaedics, nephrol-
ogy, etc.) and non-invasive specialists (rheumatology,
gastroenterology, nephrology, cardiology, etc.) using a
classification that was adopted from an earlier project
[9]. Consultation records included frequencies and costs
categorized by gender of patients, by 20 age groups, and
by community of patient residence. Consultation costs
were classified by diagnostic and therapeutic activities
(treatment cost) and by medication directly dispensed to
patients (medication cost) [4]. Data regarding referral to
consultants, imaging procedures, hospitals, pharmacies
and other services were not available.
The main outcome of this study was the sum of treat-
ment cost reimbursed to physicians by mandatory health
insurance. These costs were calculated for each physi-
cian by summing up all revenues for diagnostic and
therapeutic services (without medication cost) provided
during 2003-2007. In addition, the average cost per
patient was calculated by dividing the sum of cost by
the total number of patients treated during the same
period.
This study is exempted from ethic committee review
according to Swiss law, no individual patient records
were used in the study.
Data analysis and regression models
Descriptive analyses document the intensity of services
in terms of treatment cost per patient across medical
provider types, cantons and different drug dispensation
practices (Tables 1 and 2).
Statistical analyses used the methods described by
Grytten and Sorensen [6,10]. We analyzed effects of
patient list size on total treatment cost at the physician
or practice level using log-log models. In these models,
a linear relationship with a unitary slope between
patient numbers and treatment costs would indicate no
effect of patient list size on costs per patient, whereas
slopes below one would indicate that the intensity of
services and the related treatment cost per patient
decrease with high patient numbers and vice versa. The
slope of the regression line (i.e. the location of the sup-
ply curve) is thus of central importance as slopes above
one may indicate supplier induced demand and slopes
below can be seen as an indication of rationing of
services.
The main outcomes of these models were the total
treatment cost per physician reimbursed by basic health
insurance during 2003-2007. The first model was used
to estimate the direct relationship between patient num-
ber and total treatment cost without adjustment for
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other cofactors (model 1). Two additional regression
models accounting for demographic and geographic fac-
tors were used, one model was aimed to assess the over-
all relationship between the number of patients and
total treatments cost (model 2). A third model investi-
gated effects of different patient numbers (quartiles of
panel size) on total treatment cost (model 3). Physician
data were therefore divided into four groups (quartiles)
of patient numbers and each of these groups was stu-
died individually.
The following relationships describe the four groups
P_Q1 = log(patient number) for ≤ 1st Quartile otherwise
P_Q1 = 0
P_Q2 = log(patient number) for > 1st Quartile ≤ med-
ian otherwise P_Q2 = 0
P_Q3 = log(patient number) for > median ≤ 3rd
Quartile otherwise P_Q3 = 0
P_Q4 = log(patient number) for > 3rd Quartile other-
wise P_Q4 = 0
Additional explanatory variables were included in
models 2 and 3 in order to analyze effects of patient
demographics, geographic location of practices (cantons)
and distribution channel of prescription drugs. The
structure of the three models is given in table 3.
Type of dispensing drugs (’prescription only’, ‘self-dis-
pensation’, ‘mixed forms’) and canton of practice loca-
tion were treated as classification (i.e. categorical)
variables. Cantons were included as nested effects within
area of drug dispensation. Results of classified variables
were interpreted as least-square means (LS-Means). The
Bonferroni procedure was used to adjust for multiple
comparisons and exponents of LS-Means were used for
tables and graphs. Differences between slopes of quar-
tiles of patient numbers were determined by testing the
respective linear combinations of parameters. Residual
analyses, performed to validate the statistical procedures,
showed no evidence of assumption violations for the
models used in the analysis and R-square values
exceeded 0.9 for all models specified.
In order to quantify the effect of non-proportional
relationships between patient numbers and total practice
cost the slope estimate for patient number of model 1
was set to 1 and exponentials of predicted values of this
procedure were used to compare cost expected in a set-
ting of proportionality with observed cost. SAS 9.2 (SAS
Institute Inc., Cary, NC, USA) and “Proc GLM” were
used for all analyses, and the level of significance was
set at 0.05 throughout the study.
Results
Characteristics of physicians
The distribution of physicians across medical provider
types, average treatment costs per patient and data on
cantonal variability for 2003-2007 are shown in Table 1.
Treatment costs per patient varied markedly across can-
tons with the magnitude of variation ranging from a 1.6
fold variation for gynecology to a four-fold variation for
non-invasive specialists. Average treatment cost per
patient showed distinct regional patterns depending on
provider type and dispensing channel of prescription
drugs (Table 2). Areas with “Self dispensation” had
the lowest treatment cost per patient for primary care,
gynecology, pediatrics and for psychiatry, whereas
“prescription only” areas had lowest cost for specialists
with non-invasive and invasive activities.
Table 1 Average treatment costs (in Swiss Francs) per patient 2003-2007 across different medical care providers
Type of provider Nr of Cantonsa Nr of physicians(% of total) Average cost perpatient Interquartile range Extremal coefficientb
Primary Care 26 8149 (43%) 365.64 67.72 1.80
Gynecology 26 1249 (7%) 259.18 39.70 1.63
Pediatrics 25 972 (5%) 254.56 65.56 1.97
Non-invasive Specialists 26 2716 (14%) 498.19 196.36 4.11
Invasive Specialists 26 3039 (16%) 306.92 100.37 2.42
Psychiatrists 25 2986 (16%) 1398.94 417.51 2.84
a Pediatricians and psychiatrists were located in 25 Cantons only
b Ratio of canton with highest vs. canton with lowest cost
Table 2 Average treatment cost (in Swiss Francs) per
patient 2003-2007 across type of medical provider and
different source of drug dispensation
Type of care Self
dispensation
Mixed
forms
Prescription
only
Primary Care 345 403 (+14%)a 403 (+14%)
Gynecology 256 290 (+12%) 273 (+6%)
Pediatrics 240 266 (+10%) 271 (+11%)
Non-invasive
Specialists
635 748 (+15%) 487 (-30%)
Invasive Specialists 326 316 (-3%) 304 (-7%)
Psychiatrists 1368 1726 (+21%) 1897 (+28%)
a difference to self dispensation in brackets
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Notably, in areas with self dispensation, sales of medi-
cation accounted for 44% of total primary care practice
revenues (sum of reimbursements for treatment and for
medication). For specialists, the respective proportions
ranged from 11% for psychiatrists to 24% for specialists
performing non-invasive treatments. In areas with “pre-
scription only” dispensing the proportion of revenues of
directly dispensed medication of total practice revenues
ranged from 0.2% in psychiatry to 6% in pediatrics.
Results of regression models
Unadjusted and adjusted effect estimates of continuous
explanatory variables on overall treatment costs at the
physicians/practice level are shown in Table 4. Irrespec-
tive of number of additional cofactors included in
the models, slopes of supply curves (effect of patient
numbers on total treatment cost at the practice level)
significantly exceeded 1 for all medical provider types,
implying that treatment costs per patient increase with
higher practice size, i.e. larger practice lists. The effect
was particularly strong for psychiatry with a slope
estimate of 1.14 in the adjusted model. Furthermore,
slope estimates of supply curves of model 1 and model
2 were very similar indicating only minor effects of vari-
ables related to patient demographics and practice loca-
tion (table 4).
The overall additional costs associated with these
effects are substantial. The difference between the total
sums of observed cost for all practices and the respec-
tive expected cost under the assumption of proportion-
ality are: Primary care +61%, gynaecology +81%,
pediatrics +50%, non-invasive specialists +63%, invasive
specialists +49% and psychiatry +116%.
Models using quartiles of patient panels indicate that
slopes of supply curves generally decrease with higher
patient numbers. But slope estimates of quartiles show
different patterns across provider types and significant
and consistent decreasing slopes for quartiles 1 to 4 i.e.
a “dose-response” relationship are seen for primary care
and psychiatry only (Figure 1).
Adjusted total treatment cost also varied substantially
across cantons for all provider types. Cantonal variation
Table 3 Structure of models
Model 1 Outcome Total treatment cost per physician for 2003-2007
Explanatory variable Total number of patients treated in 2003 - 2007
Model 2 Outcome Total treatment cost per physician for 2003-2007
Explanatory variables Total number of patients treated in 2003 - 2007
Average age of patients
Proportion of consultations for female patientsa
Type of dispensing drug (prescription only, ‘self-dispensation’, mixed forms)
Canton of practice location within type of dispensing prescription drugs (nested effect)
Model 3 Outcome Total treatment cost per physician for 2003-2007
Explanatory variables Quartiles of number of patients treated 2003-2007 (P_Q1 - P_Q4)
Average age of patients
Proportion of consultations for female patientsa
Type of dispensing drug (prescription only, ‘self-dispensation’, mixed forms)
Canton of practice location within type of dispensing prescription drugs (nested effect)
a The variable was omitted in models for gynaecology
Table 4 Regression coefficients for total treatment costs at the physicians level 2003 - 2007
Model 1a Model2b
Type of care Intercept Number of patients Intercept Number of patients Average patient age % consultations for women
Primary Care 5.370 1.061c 3.304 1.064c 0.472 -0.044e
Gynecology 5.003 1.072c 4.228 1.074c 0.152 -d
Pediatry 5.145 1.046c 4.476 1.058c 0.131 -0.162
Non-invasive Specialists 5.585 1.057c 1.798 1.052c 0.815 -0.381
Invasive Specialists 5.233 1.047c 3.905 1.040c 0.224 -0.125
Psychiatrists 6.582 1.133c 5.928 1.143c -0.021e 0.022
a Model with number of patients as the only explanatory factor
b Model with number of patients, age, proportion of consultations for female patients, canton and dispensation channel as cofactors
c 95% confidence limit is not including 1
d effect was omitted from the model
e non-significant estimates
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of adjusted treatment costs (LS-Means) at the practice
level is shown in Figure 2. Significant differences of
costs across areas with different channels of drug dis-
pensation were observed for primary care, invasive and
non-invasive physicians (Table 5). Pairwise comparisons
of least square means across the three dispensation
channels indicated significant differences for all possible
combinations within these three provider types. How-
ever, the extent and direction of differences were not
consistent. Adjusted treatment costs in “prescription
only” areas were highest for primary care but lowest for
both invasive and non invasive care providers.
Figure 1 Regression coefficientsa of quartiles of patient panels (model 3). aRegression coefficients denote the location of the supply curve
and slopes above one indicate inducement of services. Slopes estimates were obtained using linear regression models. Error bars denote 95%
confidence intervals of regression coefficients.
Figure 2 Cantonal variation of adjusted treatment cost at the practice level across six medical provider typesa. a Plot symbols denote
the abbreviation of canton names and exponents of least square means of regression model 1 are shown as estimates of total treatment costs
at the expense of mandatory health insurance.
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Discussion
Our study demonstrates considerable variation in treat-
ment costs across cantons, by type of drug dispensation,
and by the number of patients cared for by each prac-
tice. Unexpectedly, larger practice lists were associated
with higher per patient costs, in both unadjusted and
adjusted models, and for all physician types studied.
Furthermore, drug dispensation policies were also asso-
ciated with differences in treatment costs. These effects
are unlikely to be explained by patient needs, and reflect
the complex incentives within the Swiss health care
system.
Effects of the health system
The Swiss health system is characterized by both liberal-
ism and federalism with many different stakeholders
involved. Cantons have a particularly strong role in reg-
ulating and financing health care [2]. The disadvantages
of the system are, among others, fragmentation and
regional variation in health care expenditures that may
not be entirely justified by medical needs of the respec-
tive populations [5,11,12]. Our results quantify cantonal
variation of treatment cost for physician based ambula-
tory care, and confirm the impact of cantonal and pro-
fessional autonomy in providing, coordinating and
financing care.
Our results reveal that sales of prescription drugs
account for considerable revenues for primary care phy-
sicians and, to a lesser degree, for other care providers.
Reimbursement data, however, show inconsistent asso-
ciations with type of drug dispensation across different
provider types of care. The dispensation channel of pre-
scription drugs, which is also regulated on a cantonal
basis, is an important aspect of the variation in costs.
Switzerland is one of the few OECD countries in which
doctors are authorized to dispense prescription non-
emergency drugs. This policy has been subject of a long
debate between physicians, pharmacists and regulators.
While self-dispensation may be a financial aid for the
struggling primary care physicians, it is may also lead to
conflicts in patient and physician interests. Patient per-
ception about benefits of self-dispensation in Switzer-
land is mixed [13] and it appears that self-dispensation
is related to higher prescription volumes in other coun-
tries [14].
Variation in service volume that does not reflect
patient need has not only direct consequences on health
care expenditures, but may trigger a cascade of unneces-
sary diagnostic tests and other procedures. While there
is a sparse literature analyzing potential effects of such
events on health outcomes and quality of care [13],
there are studies showing that higher treatment intensity
does not generally result in better health [15].
Effects of patient volume on treatment revenues at the
practice level
The study confirms and expands earlier research investi-
gating effects of structural attributes of practices on
treatment costs and volume in Swiss ambulatory care
[5,6]. The overall non-proportional relationships
between number of patients and total treatment cost, as
shown in Table 4 suggests considerable effects on over-
all treatment cost of supply induced services. Structural
differences such as better practice organization (more
staff, better equipment and IT, etc.) that allows for lar-
ger treatment volumes may at least partially provide an
explanation of such patterns. However, Swiss ambula-
tory care is based on a fee-for-service system, which
may encourage physicians to expand service volumes.
The presence of non-medical incentives to provide
higher amounts of care is further supported by decreas-
ing slope estimates of supply curves in practices with
large patient populations. These data imply reduction of
services at the patient level in these practices or, vice
versa, induction of services in practices with fewer
patients particularly for psychiatry and to lesser degree
for other provider types. Apparently, psychiatric care is
sensitive to such mechanisms as it typically lacks the
possibilities for expanding services compared to all
other provider types, i.e. by simply adding more medi-
cal-technical care. The extent to which under treatment
or overtreatment occur within these practice settings
cannot be ascertained from the present study without
further data on health outcomes and patient satisfaction.
It is, however, unlikely that the health status of patients
in practices with fewer patients differs substantially from
practices with more patients. Moreover, our studies con-
trol for patient age, one of the dominant factors of mor-
bidity. The findings extend other research [16] that high
service production may not translate into improved
Table 5 Adjusted total sum of treatment costsa in Swiss
Francs across medical discipline and group of drug
dispensation for 2003-2007
Type of care Self
dispensation
Mixed forms Prescription
only
Primary Care 296227 321077 (+8%) b 325732 (+10%)
Gynecologyc 379418 412150 (+9%) 395527 (+4%)
Pediatricsc 373214 376611 (+1%) 388110 (+4%)
Non-invasive
Specialists
374641 434273 (+16%) 352036 (-6%)
Invasive Specialists 216719 196617 (-9%) 184251 (-15%)
Psychiatrists 235053 274825 (+17%) 268355 (+14)
a Adjusted for cantonal effects, demographic structure and numbers of
patients using general, linear models (exponents of LS-means).
b difference to self dispensation in brackets.
c no significant differences of LS-Means across groups.
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health of served populations in the ambulatory sector of
Swiss health care.
Limitations and strengths
The observed association between physician activity and
treatment costs may be biased by omitted possible con-
founders, such as individual preferences of patients and
physicians. Such associations can only be explored with
qualitative research of individual treatment episodes [17].
It is also important to note that our analyses did not fully
control for differences in case-mix across the various
practices settings. Although age was used as a proxy for
health status, case mix may have biased our results parti-
cularly in psychiatry where smaller patient numbers can
be associated with a higher complexity of cases.
The study does not provide data about the effects of
the type drug dispensation scheme on overall expendi-
tures of Swiss ambulatory care. The data that would
allow such analyses, including the regional distribution
of prescription drug sales of pharmacies and ambulatory
hospital departments, are currently not available.
Another limitation is that only data for physician con-
sultations reimbursed by compulsory health insurance
were available. Out-of-pocket costs of households
accounted for 21% of 2006 overall health care expendi-
tures in Switzerland [3]. It is important, therefore, to
note that the results of this study refer only to costs
that were paid by mandatory health insurance.
The results may not be compared directly with other
countries as health systems differ with respect to struc-
ture, financing mechanisms and socio-cultural aspects.
The Swiss health care system, however, shares important
similarities with the United States - fee-for-service pay-
ments, physician owned practices, and large number of
insurers. Our findings may help highlight the dilemmas
in health care delivery and financing faced by both Swit-
zerland and the United States.
Conclusions
Our findings reveal that physicians make different deci-
sions as a function of the number of patients they see,
and that treatment patterns vary across different systems
of providing prescription drugs. The study provides
empirical evidence that payment methods for physician
services and for prescription drugs are associated with
variations in treatment costs that are unlikely to be
entirely justified by the medical needs.
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